Introduction: Acute Kidney Injury (AKI) is becoming increasingly common in both developed and developing countries with significant morbidity and mortality. However, the precise incidence of AKI in children is not well known due to lack of uniformity in various definitions of AKI. This study was carried out to compare incidence of AKI using two different definitions-pRIFLE and AKIN. Material and Methods: This was a prospective cohort study conducted in the paediatric ICU of a tertiary care government hospital attached to a Medical College of Central Gujarat, India. Total 115 critically ill paediatric patients aged one month to 12 years were included in the study. Serum Creatinine (SCr) levels were tested and Glomerular filtration rate (GFR) was calculated using the Schwartz formula at 0, 6, 12, 24 and 48 hours of admission. Patients were assessed for AKI using AKIN and pRIFLE classification. Results: Incidence of AKI was 80% and 66.9% in critically ill children, as classified by pRIFLE and AKIN classification respectively. Paediatric RIFLE labelled 15 more patients as AKI which were classified as non-AKI by AKIN criteria. There was moderate agreement in between the two classifications to diagnose stages of AKI (Kappa 0.474, CI-0.359 to 0.589). With increasing grades of AKI, mortality was higher using pRIFLE staging; unlike the AKIN staging wherein this was not observed. Conclusion: The pRIFLE criteria detects a greater number of cases of AKI compared to AKIN criteria. Based on severity staging, pRIFLE is more consistent with adverse outcome of patients with AKI compared to AKIN classification. Overall mortality is significant high in patients with AKI compared to patients without AKI using any of the classifications.
Introduction
A cute Kidney Injury (AKI) has become increasingly common in both developed and developing countries with signifi cant morbidity and mortality 1 .The precise incidence of AKI in children is not well known 1 . Prospective studies from India suggest an incidence of 4-6% of AKI in paediatric patients in general wards and up to 60% in Pediatric Intensive Care Units (PICUs) 2, 3, 4, 5 . AKI, earlier known as acute renal failure (ARF) is a term used for an abrupt and sustained decrease in glomerular fi ltration rate (GFR) resulting in retention of nitrogenous (urea and creatinine) and non-nitrogenous waste products 6 . Clinicians and paediatricians mostly use Serum Creatinine (SCr) values to analyse renal status which in fact is not a sensitive parameter. Normal SCr values in children being age dependent and usually on the lower side, elevated SCr is often misinterpreted as normal and thus, timely intervention is missed leading to further progression causing increased morbidity and mortality. It is now evident that even minimal change in SCr and GFR are associated with a dramatic increase in mortality 6 . Earlier Identifi cation of AKI in patients or 'at risk' for AKI patients can defi nitely help in deciding the management and installing measures to prevent further renal injury; like avoiding nephrotoxic drugs and appropriate fl uid management, and, thereby preventing morbidity and mortality arising due to it. The reported mortality from AKI is still as high as 60% in critically ill children. 7 The lack of a precise biochemical defi nition of ARF resulted in at least 35 defi nitions in the medical literature 8 , which gave rise to a wide variation in reported incidence and clinical signifi cance of ARF and impeded a meaningful comparison of studies that assess preventive and therapeutic strategies. As there was no standardized defi nition of AKI, Acute Dialysis Quality Initiative Group devised the Risk, Injury, Failure, Loss, End Stage Renal Disease (RIFLE) criteria in 2004, which were subsequently modifi ed in 2007. The fi rst modifi cation viz. 'the paediatric RIFLE (pRIFLE)' was made to adapt this defi nition for its use in children 3 . The RIFLE system defi nes AKI by a change in SCr level or eGFR from a baseline value and urine output per kilogram of body weight over a specifi ed time period 9 . The second modifi cation was made by Acute Kidney Injury Network (AKIN) which defi ned AKI based on the RIFLE system but adds an absolute change in SCr of ≥0.3 mg/dL, omits eGFR criteria and includes a time constraint of 48 hours 10 . The AKIN system also omits the stages "Loss" and "End-stage" and allocates patients who needed acute dialysis to stage-3 11 . Despite modifi cations considered under these defi nitions, none of them has been proven superior and accepted as a universal standardized defi nition. There are studies with totally diff erent defi nitions of AKI based on absolute change in SCr rather than relative change in SCr 12 . There are few studies comparing defi nitions of AKI in adults 10, 13, 14, 15 , but very limited studies comparing them in children especially from developing countries 14 .The aim of this study was to compare classifi cation of Acute Kidney Injury using two diff erent defi nitions -pRIFLE and AKIN in terms of incidence and outcome of critically sick children.
Material and Methods
This is a prospective cohort study carried out at Paediatric intensive care unit of a tertiary care hospital, attached to a Government Medical College of Central Gujarat, India. This study was carried out over a period of six months from April 2013 to September 2013. Ethical clearance was obtained from Institutional Ethics Committee on Human Research. Critically ill children of age one month to 12 years admitted in Paediatric intensive Care unit during this period were included in the study. Patients with chronic kidney diseases, S. Bilirubin > 5 mg/dL and patients with hospital stay for less than 24 hours were excluded from study. They were enrolled after obtaining informed written consent form parents. Sample size was deduced using 5% allowable error (α) and power of study (β) 80%. The incidence of AKI in children is approximately 5% among non-critically ill 16, 17 and 30% in critically ill 18, 19 . In order to estimate these incidence rates at 95% confi dence, the required sample size was 104. Expecting 10% refusal and loss to follow up, the estimated sample size was 115. In the study period, we screened 146 patients, of which 115 were enrolled in the study. Patients' demographic characteristics, clinical profi le, physiological parameters, laboratory investigations, outcome data and necessary information were recorded in a pre-designed performa. SCr was estimated on Mura 300 auto-analyser by modifi ed Jaff e method 20 at admission and then at 6, 12, 24 and 48 hours of admission. Subsequently, the estimation was done at daily interval in patients with AKI. Baseline SCr was determined by using backward calculation as recommended by Kidney Disease Improving Global Outcomes Group (KDIGO) 14 from the normal GFR for the given age (for paediatric population). These standardized GFR values were also taken as the baseline GFR for purpose of staging of patients according to pRIFLE criteria. Estimated creatinine clearance (eCCl) were calculated at 6,12, 24,and 48 of admission using the Schwartz formula 21 . Urine output criteria were not applied. Data of the patients were reviewed daily and patients were assigned to the appropriate pRIFLE strata (R, I or, F), AKIN staging (Stage I, II, III) 9, 22 . In case the patients progressed from a milder stage to a more severe stage of AKI, the worst or the most severe category was assigned for pRIFLE and AKIN staging respectively.
Statistical Analysis: Data was entered in MS Excel 2007 and analysed using SPSS software version 18 which is a statistical analytical tool 23 . Incidence of AKI and demographic characteristics were expressed in terms of percentages and proportions. Agreement between the two classifi cations for staging of AKI was calculated using Kappa statistic. Probability value (p-value) less than 0.05 was considered statistically signifi cant.
Results
Characteristics of the study cohort: Out of 146 patients screened, 31 did not meet the inclusion criteria and were excluded (due to hospital stay being less than 48 hours (8) , mortality within 48 hours (10), chronic kidney condition (7) and Serum bilirubin >5 mg/ dl (6) Figure 1 . Of 115 patients included in this study, 70 (60.8%) were discharged, 38 (33.04%) expired and seven (6.05%) left against medical advice. There were 43 (37.3%) females and 72 (62.6%) males. 
Stage of AKI and outcome:
Of the 115 patients included in this study, 38 (33.04%) expired. Renal replacement therapy was needed in three out of 92 patients of AKI. All of these patients were classifi ed as "failure" category of AKI by pRIFLE classifi cation. Two out of these three patients expired while one patient; whose peritoneal dialysis was done for four days, was discharged.
The overall mortality rate of patients with AKI (pRIFLE) was 39.1% (n=36/92) while that in non-AKI patients was 5.3% (n=2/23) (Chi-square=7.64, p value 0.005). Mortality rate among patients classifi ed as having AKI as per AKIN classifi cation was 42.8% (n=33/77) and in non-AKI patients was 13.2% (n=5/38) (Chi-square=10.06, p-value 0.001). Stage wise mortality has been shown in Table 2 . With pRIFLE staging, the mortality observer was higher with higher grade of AKI, such relation of outcome was not observed with AKIN staging ( Table 2) . 
Agreement between two defi nitions:

Discussion
This study is one of the limited studies conducted among the paediatric groups in India to know the incidence of AKI and compare the same using two diff erent modifi ed classifi cations viz. pRIFLE and AKIN in critically ill children.
Paediatric RIFLE not only detected more subjects with AKI, but also had more patients in higher stage of disease compared to AKIN classifi cation. Out of the 115 patients included in this study, more than three fourths (80%) had AKI as per pRIFLE criteria while two-thirds (66.9%) had AKI according to AKIN criteria.
A study done at All India Institute of Medical Sciences, New Delhi by Poonam Mehta et al 24 suggested an incidence of 36.1% in the critically ill patients. These fi ndings were based on AKIN staging. Another study by WF Hui 25 , using the pRIFLE score estimated the incidence to be 56% in a paediatric intensive care unit of a regional Hong Kong hospital.
Arikan-Akcan A 9 showed an incidence of 82% of AKI in critically ill patients of Texas children's Hospital, USA. This study had modifi ed the RIFLE criteria for paediatric patients as pRIFLE and suggested that majority of critically ill children develop acute kidney injury early in the course of intensive care. Few studies 9,24,25 had taken the fi rst day creatinine as baseline and in those cases where the SCr levels were either missed or unavailable, it was calculated using the Modifi cation of Diet in Renal Disease (MDRD) formula. In our study, we have taken the baseline SCr by reverse calculation from the standard GFR for the given age and sex as recommended by KDIGO 26 . This was done to maintain uniformity while grading patients for AKI based on AKIN classifi cation and pRIFLE classifi cation and also to make them comparable. MDRD formula is mainly used for adults while for patients less than 18 years and children, Schwartz formula is recommended, which has better precision and accuracy. This may be one of the reasons for high incidence of AKI in our study. A pre-morbid 'baseline' creatinine is required in order to diagnose and stage acute kidney injury (AKI) using the RIFLE classifi cation. Estimation of baseline creatinine by solving the (MDRD) equation assuming a glomerular fi ltration rate of 75 ml/min/1.73 m 2 has been widely used but never validated 27 . Also, GFR is a more sensitive indicator than SCr as measure of AKI and this may be the reason for higher incidence of AKI according to pRIFLE classifi cation. This high incidence may also 
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Failure n=25 pRIFLE be attributed to our study population who were critically ill (our hospital being a tertiary care center) and thus more prone for AKI. Most of the critically ill patients have subclinical dehydration on admission due to poor oral intake making them prone for elevated serum creatinine levels. Thus, there may be a high chance of misclassifi cation of these patients as non-AKI based on the fi rst creatinine value on admission 28 . There are at least 35 defi nitions for AKI in the medical literature which gave rise to wide variation in reported incidence. Clinicians should exercise caution when classifying patients with AKI as per any of the classifi cation system when a baseline SCr is unknown. It would be important to consider the goal of AKI classifi cation when selecting a baseline. For clinical purposes, it may be important 'not to miss' any case of potential AKI, so it would be prudent to use the classifi cation with better sensitivity. In developing countries, where malnutrition is very much prevalent, using classifi cation based on SCr may lead to erroneous results, as SCr also depends on muscle mass.
In our study, there was higher incidence of AKI in younger patient but this was not signifi cant statistically which might be due to small sample size. In a study carried out by Mehta et al 24 the mean age of patients with AKI was 24 months whereas in patients with no AKI the mean age was 48 months. In this study, the age group of patients included in the study was one month to 18 years. Similarly, in a study done by Arikan-Akcan A et al 9 the mean age of patients with AKI was 6.4 years among 150 patients of age group one month to 21 years. In study by Mehta 24 where 95.9% patients of AKI had ATN.
The overall mortality rates of patients with AKI (according to pRIFLE and AKIN classifi cations) were statistically higher than that in non-AKI patients. It was found that as the category of AKI (graded as per pRIFLE) increases, the risk of mortality in patients' increases. It was seen that mortality nearly doubles as patient progresses to injury and failure from risk category. This was, however, not noted among the increasing grade of AKI as per AKIN classifi cation. Ideally any classifi cation, with increasing grades, shows more severity and thereby, should have poorer outcomes. However, this was not the case in AKIN classifi cation.
The study by Arikan-Akcan A concluded as having no diff erence in overall mortality rates between patients of AKI(14.6%) and those without having AKI(11.1%) 9 . However, patients with pRIFLEmax injury or failure had twice the mortality than patients with pRIFLEmax risk or controls. The study by Hui et al concluded that mortality in patients with AKI was 12% compared to two percent in those without AKI 25 .
In both the above studies 9, 25 , pRIFLE was used to classify patients in AKI. None of the results have used the AKIN classifi cation. Any factor that potentially aff ects mortality during PICU stay could confound the association between AKI and mortality. Also, the initial design of RIFLE was not to predict mortality, but provide a classifi cation scheme to identify various degrees of clinical severity. Moderate agreement was seen during staging of AKI patients by either pRIFLE or AKIN. Only one patient was misclassifi ed by pRIFLE which was identifi ed as AKI by AKIN classifi cation.
Conclusion
The pRIFLE criteria detects a greater number of cases with AKI compared to AKIN criteria. Based on severity staging, pRIFLE is more consistent with adverse outcome of patients with AKI compared to AKIN classifi cation. Overall mortality is signifi cant high in patients with AKI compared to patients without AKI using any of the classifi cations.
Limitations
Potential limitations of our study include the relatively small sample size of 115 patients. Data was restricted to a single study center. Another potential concern was non-availability of actual baseline SCr values. We did not apply urine output criteria for AKI. Urine output criteria also have its own limitations like children having non-oliguric renal failure and urine output can get aff ected by use of diuretics. Lack of unavailability of a gold standard for comparison of the classifi cations is one of the setbacks; though novel biomarkers are available, none of them has been established as a gold standard. In future these novel biomarkers might come up as reliable markers of AKI or integration of such markers in these classifi cations might increase the sensitivity and specifi city of these classifi cations.
